Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
Since 2002, Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders. The Company is advancing a diversified portfolio of clinical candidates across Oncology and Inflammation & Autoimmunity.
Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.
For more information, visit Incyte.com and follow @Incyte.
Proof of COVID-19 vaccination is required for this event. All guests will be asked to show proof of vaccination and a photo I.D. upon arrival.
You may also email a copy of your vaccination card in advance to kwelcher@dscc.com
A light breakfast will be provided.
Free
Click here to register.
Delaware's Governor
State Agencies
Elected Officials
General Assembly
Delaware Courts
State Employees
Cities & Towns
Delaware State Code
State Regulations
Business First Steps
Phone Directory
Locations Directory
Public Meetings
Voting & Elections
Transparency
Delaware Marketplace
Tax Center
Personal Income Tax
Privacy Policy
Weather & Travel
Contact Us
Corporations
Franchise Tax
Gross Receipts Tax
Withholding Tax
Delaware Topics
Help Center
Mobile Apps
E-mail / Text Alerts
Social Media
Built by the Government Information Center
©MMXXIV Delaware.gov
